Angela C. Hirbe

Washington University School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (11)

Phioanh Nghiemphu

University of California, Los Angeles

UNITED STATES

View details

Laura J Klesse

University of Texas Southwestern Medical School

UNITED STATES

View details

Steven Robinson

Associate Professor of Oncology

Mayo Clinic Minnesota

UNITED STATES

View details

Timothy Gershon

Acting Professor, Director, Children's Center for Neurosciences Research

Emory University

UNITED STATES

View details

Mohammed Milhem

Oncology Section Chief

University of Iowa Healthcare

UNITED STATES

View details

Robin Jones

Consultant Medical Oncology, Head of Sarcoma Unit,

Royal Marsden NHS Foundation Trust

UNITED KINGDOM

View details

Varun Monga

Clinical Associate Professor

University of California San Francisco Medical Center

UNITED STATES

View details

Brian Van Tine

Associate Prof.

Washington University in St. Louis

UNITED STATES

View details

John S A Chrisinger

UNITED STATES

View details

Keith Skubitz

Professor

University of Minnesota

UNITED STATES

View details

Amy Armstrong

Assistant Professor

Washington University Physicians

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Angela C. Hirbe

Research Interests

Explore related searches

Contact this professor

Articles (20)

Reply to: Challenges in Assessing Response in Clinical Trials for Neurofibromatosis Type 1 Plexiform Neurofibromas

Mirdametinib, an FDA-Approved MEK1/2 inhibitor for adult and pediatric NF1-associated plexiform neurofibromas

Phase II Study of Pexidartinib Plus Sirolimus in Unresectable Malignant Peripheral Nerve Sheath Tumors Identifies M2 Macrophage Activation

ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma

A Sequencing Overview of Malignant Peripheral Nerve Sheath Tumors: Findings and Implications for Treatment

UBR5 in Tumor Biology: Exploring Mechanisms of Immune Regulation and Possible Therapeutic Implications in MPNST

Brain Metastases in Sarcomas: A Multicenter Retrospective Cohort Study

Contemporary Approach to Neurofibromatosis Type 1–Associated Malignant Peripheral Nerve Sheath Tumors

The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma

A Retrospective Multi-Institutional Cohort Analysis of Clinical Characteristics and Outcomes in Dedifferentiated Chondrosarcoma

Loss of Chromosome 3q Is a Prognostic Marker in Fusion-Negative Rhabdomyosarcoma

Loss of Chromosome 3q Is a Prognostic Marker in Fusion-Negative Rhabdomyosarcoma

A Systematic Review of Recent and Ongoing Clinical Trials in Patients With the Neurofibromatoses

Plexiform neurofibroma: shedding light on the investigational agents in clinical trials

The Impact of TSC-1 and -2 Mutations on Response to Therapy in Malignant PEComa: A Multicenter Retrospective Analysis

A Phase I Study of the Combination of Pexidartinib and Sirolimus to Target Tumor-Associated Macrophages in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors

An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma

Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma

Patterns of Extrapulmonary Metastases in Sarcoma Surveillance

Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas

Collaborators (11)

Phioanh Nghiemphu

Laura J Klesse

Steven Robinson

Timothy Gershon

Mohammed Milhem

Robin Jones

Varun Monga

Brian Van Tine

John S A Chrisinger

Keith Skubitz

Amy Armstrong

Make your next move.